These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 18375359)

  • 21. [Immunotherapy of malignant melanoma--basic principles and novel therapeutic approaches].
    Enk AH; Becker JC; Schuler G
    J Dtsch Dermatol Ges; 2006 Aug; 4(8):635-45. PubMed ID: 16895565
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunotherapy of melanoma.
    Rietschel P; Chapman PB
    Hematol Oncol Clin North Am; 2006 Jun; 20(3):751-66. PubMed ID: 16762733
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunotherapy for malignant melanoma--tracing Ariadne's thread through the labyrinth.
    Grange JM; Krone B; Stanford JL
    Eur J Cancer; 2009 Sep; 45(13):2266-73. PubMed ID: 19497734
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Individualized therapy of disseminated cancer using malignant melanoma as a model.
    Hauschild A; Egberts F; Russo P; Kähler KC
    Cancer Metastasis Rev; 2006 Jun; 25(2):253-6. PubMed ID: 16770537
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment approaches for advanced cutaneous melanoma.
    Stein JA; Brownell I
    J Drugs Dermatol; 2008 Feb; 7(2):175-9. PubMed ID: 18335655
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Melanoma vaccines.
    Naylor MF
    Dermatol Online J; 2000 Sep; 6(1):5. PubMed ID: 11328615
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anticytotoxic T lymphocyte-associated antigen 4 treatment--can melanoma be cured at the expense of autoimmune disorders?
    Lejeune FJ
    Melanoma Res; 2006 Oct; 16(5):377-8. PubMed ID: 17013085
    [No Abstract]   [Full Text] [Related]  

  • 28. [The role of immunotherapy in the treatment of patients with hematologic neoplasms].
    Rukavitsyn OA
    Vopr Onkol; 2002; 48(2):186-92. PubMed ID: 12227066
    [No Abstract]   [Full Text] [Related]  

  • 29. Immunotherapy for melanoma.
    Weber J
    Curr Opin Oncol; 2011 Mar; 23(2):163-9. PubMed ID: 21192262
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Therapeutic vaccines in solid tumours: can they be harmful?
    Eggermont AM
    Eur J Cancer; 2009 Aug; 45(12):2087-90. PubMed ID: 19477117
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Systemic therapy for melanoma.
    Ganesan P; Bakhshi S
    Natl Med J India; 2010; 23(1):21-7. PubMed ID: 20839588
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dendritic cell-based vaccines for pancreatic cancer and melanoma.
    Mulé JJ
    Ann N Y Acad Sci; 2009 Sep; 1174():33-40. PubMed ID: 19769734
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tumor vaccines: a role in preventing recurrence in melanoma?
    Sabel MS; Sondak VK
    Am J Clin Dermatol; 2002; 3(9):609-16. PubMed ID: 12444803
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Systemic treatment of metastatic melanoma: new approaches.
    Hamid O; Boasberg PD; Rosenthal K; O'Day SJ
    J Surg Oncol; 2011 Sep; 104(4):425-9. PubMed ID: 21858838
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Current immunotherapeutic strategies in malignant melanoma.
    Agostino NM; Ali A; Nair SG; Mosca PJ
    Surg Oncol Clin N Am; 2007 Oct; 16(4):945-73, xi. PubMed ID: 18022553
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Research progress in advanced melanoma.
    Luo C; Shen J
    Cancer Lett; 2017 Jul; 397():120-126. PubMed ID: 28385603
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Update on vaccines for high-risk melanoma.
    Weiss SA; Chandra S; Pavlick AC
    Curr Treat Options Oncol; 2014 Jun; 15(2):269-80. PubMed ID: 24788575
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Malignant melanoma of the anal region.
    Heyn J; Placzek M; Ozimek A; Baumgaertner AK; Siebeck M; Volkenandt M
    Clin Exp Dermatol; 2007 Sep; 32(5):603-7. PubMed ID: 17376215
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Peptide vaccines for patients with acute myeloid leukemia.
    Schmitt M; Casalegno-Garduño R; Xu X; Schmitt A
    Expert Rev Vaccines; 2009 Oct; 8(10):1415-25. PubMed ID: 19803762
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targets of protective tumor immunity.
    Dranoff G
    Ann N Y Acad Sci; 2009 Sep; 1174():74-80. PubMed ID: 19769739
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.